Sponsors (2)
The bill aims to raise awareness and target screening to detect esophageal cancers earlier—potentially saving lives and improving program transparency—while risking higher demand and costs, capacity strain, and possible inequities from demographic-targeted screening.
People at higher risk (older males, smokers, people with chronic GERD or obesity) and others reached by awareness efforts are more likely to get earlier screening and diagnosis, which increases chances of detecting esophageal cancers at an early stage and materially improves 5‑year survival for those cases.
Clinicians and health systems get clearer AGA risk-factor guidance to better target screening toward higher-risk patients, helping allocate limited endoscopy capacity more efficiently and focus diagnostics where benefit is greatest.
Federal employees, retirees, and policymakers will have better transparency on FEHBP spending and screening rates through a GAO report, enabling identification of screening gaps and informing potential program or coverage changes.
Patients and insurers could face higher demand for upper endoscopies, increasing healthcare costs (out-of-pocket and insurer spending) and straining endoscopy capacity, which may lead to longer wait times and access bottlenecks.
Racial and demographic targeting (e.g., emphasizing male, non‑Hispanic white, age 50+) risks missing cases in other groups and could worsen inequities in who receives diagnostic attention and timely care.
Taxpayers and FEHBP plans may incur administrative costs to produce the GAO report, and the findings could prompt future coverage or screening requirements that increase plan costs or premiums for federal employees and retirees.
Based on analysis of 3 sections of legislative text.
Requires GAO to report within 1 year on FEHBP spending for esophageal cancer and how often high-risk FEHBP beneficiaries receive guideline-recommended screening.
Requires the Government Accountability Office to study esophageal cancer care for Federal employees and retirees covered by the Federal Employees Health Benefits Program (FEHBP). The GAO must report within one year on total FEHBP spending for people diagnosed with esophageal cancer and on how often FEHBP-covered individuals flagged as high-risk receive guideline-recommended screening.
Official title: To require the Government Accountability Office to produce a report on esophageal cancer, and for other purposes.
Introduced May 19, 2025 by Gerald E. Connolly · Last progress June 9, 2026